Developing an RNA Therapy for Rare Hereditary Nerve Disease @UniversityHospitals
Developing an RNA Therapy for Rare Hereditary Nerve Disease  @UniversityHospitals
Uploaded April 2026 | Updated November 2026, 3 days ago
Haiyan Zhou, MD, PhD, University College London, 2024 Oxford-Harrington Rare Disease Scholar, is advancing a targeted RNA therapy for hereditary sensory neuropathy, a rare and debilitating nerve disorder with no current treatment options, offering hope for patients and families. The Oxford-Harrington Rare Disease Centre is a transatlantic initiative dedicated to accelerating breakthrough treatments and cures for rare diseases. Learn more: OxfordHarrington.org.
Developing an RNA Therapy for Rare Hereditary Nerve DiseaseScrolling, Stress and the Teenage Brain: How EEG Biomarkers and Self-Management Can Change the StoryOvarian Tissue Transplants Provide New Hope to Women with Ovarian InsufficiencyGreat care - UH Seidman Cancer CenterUniversity Hospitals ENT Residency Program at Louis Stokes Cleveland VA Medical CenterWhat is the PCICUAlexander Wang, MD - Neurology, Movement DisordersLife as a First-Year ENT Resident at University Hospitals Cleveland Medical CenterLeonidas Tapias, MD - Thoracic & Esophageal SurgeryHaitham Sahawneh, MD - OphthalmologyGraham Chapman, MD - Gynecologic OncologyApplications of Artificial Intelligence in Medicine and Surgery: Promise and Peril
University Hospitals |

Developing an RNA Therapy for Rare Hereditary Nerve Disease

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER